Piper Sandler Maintains Neutral on Silk Road Medical, Lowers Price Target to $11
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Adam Maeder maintains a Neutral rating on Silk Road Medical (NASDAQ:SILK) and lowers the price target from $25 to $11.
October 11, 2023 | 4:04 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Piper Sandler has lowered the price target for Silk Road Medical from $25 to $11 while maintaining a Neutral rating.
The lowering of the price target by Piper Sandler indicates a potential decrease in the stock's value. This could lead to a negative short-term impact on the stock's price as it may cause investors to reassess their positions.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100